Recent Articles from GlobeNewswire

CHARLOTTE, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Terrestrial Energy Inc. (NASDAQ: IMSR) will report its fourth quarter and full year 2025 earnings before the market opens on Monday, March 30th, 2026, and will hold a conference call at 8:30am ET that day.A live webcast of the conference call will be made available on the Events section of Terrestrial Energy’s investor relations website at https://ir.terrestrialenergy.com. The earnings release and presentation will also be posted to the investor relations website prior to the conference call.The live conference call may also be accessed by dialing (877) 407-0779 or (201) 389-0914. For those unable to listen to the live conference call, a replay will be available after the call through the archived webcast in the Events section of Terrestrial Energy’s investor relations website or by dialing (844) 512-2921 or (412) 317-6671. The access code for the replay is 13759061. The replay will be available until 11:59 PM ET on April 13th, 2026.

Recent milestones include strategic collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for pediatric cancers, with meaningful downstream commercial revenue potential

PURCHASE, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented an analysis from the Phase 2 COG1201 SHIMMER study (NCT05225415) of zervimesine (CT1812) in dementia with Lewy bodies (DLB) at the AD/PD™ 2026 Alzheimer's & Parkinson's Diseases Conference. The conference is being conducted March 17-21, 2026 in Copenhagen, Denmark. The analysis focuses on Zervimesine’s treatment effects on the behavioral and psychiatric symptoms most commonly associated with DLB.

Sherman Oaks, CA, March 17, 2026 (GLOBE NEWSWIRE) -- Xsolla SPAC 1, a newly organized special purpose acquisition company formed as a Cayman Islands exempted company (Nasdaq: XSLLU) (the “Company”), announced today that, commencing March 18, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.

COLUMBIA, Md., March 17, 2026 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. ("Rekor" or the "Company"), a leader in developing and implementing state-of-the-art roadway intelligence systems, today announced that it will report its annual financial results for the fiscal year ended December 31, 2025, on Tuesday, March 31, 2026, after market close. On the same day, the Company will host its earnings conference call at 4:30 p.m. Eastern Time to discuss financial and operating results.

- First ZEVASKYN® commercial patient treatment completed in December -

New product from game-based learning leaders designed to boost daily practice and student math scores is available now at zero-cost for all teachers

HONG KONG and LONDON, March 17, 2026 (GLOBE NEWSWIRE) -- EV Cargo, a leading global transport and logistics services provider, today announced a strategic decision to focus on global forwarding and related logistics services as the core of its future growth, building on more than 60 years of heritage dating back to Allport’s founding in 1963.

A new Battery as a Service model designed to reduce downtime, extend battery life and optimize fleet operations

Sam Asher is recognized for his leadership excellence in Aerospace & Defense

New offering pairs eight coaching-grade 360s with a people scientist-led team debrief, starting at $2,500

WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has received a letter from the Bioequivalence Program of the FDA Office of Generic Drugs stating that “FDA has not identified any bioequivalence deficiencies at this time.” The determination is deemed preliminary until final supervisory review of NRx’s Abbreviated New Drug Application with anticipated approval in Summer 2026.

BURLINGTON, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes, today announced that it will report financial results for the fourth quarter and full year 2025 and provide business updates on Tuesday, March 24, 2026, at 4:30 p.m. ET.

CARY, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- The Accreditation Commission for Health Care (ACHC) has partnered with the Immunoglobulin National Society (IgNS) to launch the Distinction in Immunoglobulin Therapy. This new Distinction offers specialty and infusion pharmacies a formal path to demonstrate advanced clinical and operational excellence in the delivery of immunoglobulin (Ig) therapy across all sites of care.

SHANGHAI, China, March 17, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Peer-Reviewed Data Show Durable HbA1c Reduction, Significant Weight Loss, and a Favorable Safety Profile Through 48 Weeks Following a Single Endoscopic Procedure for Type 2 Diabetes

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipated in H2 2026

MONTRÉAL, March 17, 2026 (GLOBE NEWSWIRE) -- Troilus Mining Corp. (formerly Troilus Gold Corp.) (“Troilus” or the “Company”; TSX: TLG, OTCQX: CHXMF; FSE: CM5) is pleased to announce that it has signed a Memorandum of Understanding (“MoU” or the “Agreement”) with Boliden Commercial AB (“Boliden”), a leading European base and precious metals mining and processing company, for the long-term offtake of copper-gold concentrate from the Company’s Troilus Project (the “Project”) in north-central Québec, Canada.

Q4 GAAP revenue of $104.5 million increased 317.7% year-over-year, driven by recently closed M&A transactions

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, today announced that, as part of its capital allocation program, it has entered into an accelerated share repurchase agreement (the “ASR”) with Morgan Stanley & Co. LLC to repurchase $125 million of the company’s common stock.

The Idaho‑Based Energy Generation Project Advances Toward Construction as rPlus Energies Scales Across the American West

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (Nasdaq: GYRE), a San Diego-based innovative commercial stage biopharmaceutical company with operations in the United States and China, today announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted priority review status to the New Drug Application (NDA) for Hydronidone (F351) as a treatment for chronic hepatitis B (CHB)-induced liver fibrosis, which is liver damage resulting from the infection of the hepatitis B virus (HBV). This decision by CDE was made following the pre-NDA communication meeting previously announced on January 5, 2026 and is a major milestone in the NDA process. Gyre, through its majority-owned subsidiary, Gyre Pharmaceuticals Co., Ltd. (Gyre Pharmaceuticals), plans to submit a formal NDA in the near future.

Minimum Bid Price Requirement

LONDON, March 17, 2026 (GLOBE NEWSWIRE) -- Cambridge Atomworks is pleased to have signed a Memorandum of Understanding with Mott MacDonald as we look to accelerate our development of the Odin microreactor with Mott MacDonalds’s specialist support and expertise.

Former AB InBev executives reunite to help brands turn AI into real revenue at MorningAI

SHANGHAI, China, March 17, 2026 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading lifestyle group in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the peer-reviewed publication of results from its ongoing four-part Phase 2a study (NCT05660642) evaluating BPL-003 (mebufotenin benzoate nasal spray) in patients with treatment-resistant depression (TRD). Published in the Journal of Psychopharmacology, the newly reported data come from Cohort 1 – a 12 week, open-label trial of a single 10 mg intranasal dose of BPL-003 in 12 patients with moderate-to-severe TRD who were not taking concomitant antidepressants. BPL-003 produced a mean Montgomery–Åsberg Depression Rating Scale (MADRS) total score reduction of 12.6 points by Day 2 (from a baseline mean of 27.5 to 14.8), which was sustained over 12 weeks to a mean MADRS score of 14.5 at Day 85. A response rate (≥50% MADRS reduction) of 54.5% was observed from the day after dosing through Day 85, and 63.6% of patients achieved remission (MADRS ≤10) at one or more timepoints. Mean Snaith-Hamilton Pleasure Scale (SHAPS) scores also improved from 8.4 at baseline to 1.5 at Day 85, indicating an absence of anhedonia. BPL-003 was well tolerated with no serious adverse events and no treatment withdrawals due to adverse events. Most adverse events were transient and mild-to-moderate in severity.

Curated assortments at today's most influential online retail destinations bring Lulus' signature occasionwear to more shoppers

While 90% of sales teams record their meetings, 74% fail to act on them; Vendasta’s new AI Workforce capability automates the lifecycle from conversation to revenue.

SHENZHEN, China, March 17, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced that it plans to release its second half and full year 2025 unaudited financial results before the U.S. market opens on Friday, March 27, 2026.

AI-powered Demand Reallocation Platform transforms retail and guest experience in the post-booking period, enabling smoother journeys and optimized performance

AI and robotics to help U.S. Navy achieve 80% fleet readiness by 2027

MEXICO CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico, S.A.B. de C.V. (“Aeroméxico” or the “Company”) (BMV & NYSE: AERO) today announced that it has been informed by certain members of its Board of Directors (the “Board”) and its executive management team that, using their personal resources and acting individually, they have acquired common shares and American Depositary Shares (“ADSs”) of the Company in the open market in Mexico and the United States, as applicable, in an aggregate amount of 1,032,120, common shares, equivalent to 103,212 ADSs.

Financial Education Hub Will Serve University Community and New River, Roanoke Valleys

Leading Online Retailer Embraces Role as a Powerful Economic Engine for Small Businesses

New digital card platform offers a unified alternative to fragmented manufacturer programs, giving employers enhanced control over the Budget, Behavior, and Biology of obesity care

Deployment in one of Europe’s leading HPC facilities moves photonic co-processing into rigorous production evaluation to address AI’s energy problems

BEIJING, March 17, 2026 (GLOBE NEWSWIRE) -- BingEx Limited (the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier service provider in China (branded as “FlashEx”), today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.

BEIJING, March 17, 2026 (GLOBE NEWSWIRE) -- 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced its unaudited financial results for the six months and fiscal year ended December 31, 2025.

HONG KONG, March 17, 2026 (GLOBE NEWSWIRE) -- Mongolian Mining Corporation (“MMC” or the “Company”, and together with its subsidiaries, the “Group”; stock code: 975), the largest producer and exporter of washed coking coal products in Mongolia, today announced its annual results for the year ended 31 December 2025 (“FY2025” or the “Year”).

NANTONG, China, March 17, 2026 (GLOBE NEWSWIRE) -- On March 13, the Sigen New Energy Nantong Smart Energy Center, located in the Su-Xi-Tong Science and Technology Park, officially commenced operations. Nearly 2,000 partners and representatives from government and business around the world witnessed the event.

LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- As the "Minimalist Parenting" and Evidence-Based Care movements hit the mainstream, a quiet revolution is reshaping nurseries across North America. The criteria for choosing baby gear have shifted fundamentally. For the modern parent in 2026, a sleep sack’s aesthetic has taken a backseat to one non-negotiable keyword: "Proven."

Jinhua, China, March 17, 2026 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (the “Company” or “Kandi Technologies”) (NASDAQ GS: KNDI), a global innovator in intelligent equipment and a technology-driven platform company, today announced that it has entered into a strategic partnership agreement with HawkRobo Systems LLC, a pioneering leader in intelligent robotics, to jointly establish KH Robotics, a joint venture aimed at accelerating the commercialization and deployment of autonomous quadruped security robots in the North American market.

MARS Snacking, Pacsun will take the License Global stage in a panel moderated by CAA Brand Management

The UK’s leading mental health charity replaces legacy tools with a modern integration platform to improve data quality, governance, and delivery speed.

Progress on share buyback programme

STMicroelectronics expands 800 VDC AI datacenter power conversion portfolio with new 12V and 6V architectures in collaboration with NVIDIA

LONDON and PHILADELPHIA, March 17, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced it will deliver two presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place from 17 April 2026 to 22 April 2026 in San Diego, California, USA.

BROOKFIELD, NEWS, March 16, 2026 (GLOBE NEWSWIRE) -- Brookfield Infrastructure (NYSE: BIP, BIPC; TSX: BIP.UN, BIPC) today announced that it has filed its 2025 annual reports on Forms 20-F, including its audited financial statements for the year ended December 31, 2025, with the SEC on EDGAR at https://sec.gov, as well as with the Canadian securities authorities on SEDAR+ at https://sedarplus.ca. These documents are also available at https://bip.brookfield.com (or for Brookfield Infrastructure Corporation, at https://bip.brookfield.com/bipc) under the Annual Reports section. Hard copies will be provided to unitholders and shareholders free of charge upon request.

SAN JOSE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD; HKEX: 0800), a global leader in autonomous driving technology, showcased its Robotaxi GXR at NVIDIA GTC 2026 today, expanding the model's global appearance. Building on the strategic partnership with Grab, Southeast Asia’s leading superapp and a WeRide shareholder, WeRide looks forward to introducing the vehicle across key Southeast Asian markets over time.

Skild AI is partnering with ABB Robotics and Universal Robots to deploy its omni-bodied robot brain across industries and applications, from factory floors to collaborative systems, without task-by-task reprogramming

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ:METC) investors of the March 31, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Ramaco securities between July 31, 2025 through October 23, 2025 (“the Class Period”).

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Navan, Inc. (“Navan” or the “Company”) (NASDAQ:NAVN) investors of the April 24, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who purchased securities pursuant to the registration statement and prospectus (collectively “Offering Documents”) issued in connection with the Company’s October 2025 initial public offering (“IPO”).

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ:LAKE) investors of the April 24, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.

Greensboro, N.C., March 16, 2026 (GLOBE NEWSWIRE) -- TEL, one of the U.S.’s largest fleet leasing providers, has placed an order for 400 Volvo VNLs – Volvo Trucks North America’s new flagship model for long-haul transport. This marks one of the largest Volvo VNL orders to date. 

Thomas J. Powell, et al. v. Securities and Exchange Commission

Enhanced capabilities using NVIDIA tech stack to accelerate deployment of secure, compliant AI solutions across regulated industries

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

Amsterdam, 16 March 2026 --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") has published its 2025 Annual Report.

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, NY, March 16, 2026 (GLOBE NEWSWIRE) -- Seventy-six percent of marketing executives cannot measure return on investment from sports sponsorships, creating unprecedented pressure as the global sports market reaches $600 billion.

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

Monster’s Pro Riders Helped Churn the Emerald Waters – Monster Style!

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) --

EAGLE, Idaho, March 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2026.

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU) reported financial results for the third fiscal quarter ended January 31, 2026.

WALTHAM, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on March 16, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 235,700 shares of the Company’s common stock (“Stock Options”) and an aggregate of 33,450 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).

GRAND CAYMAN, Cayman Islands, March 16, 2026 (GLOBE NEWSWIRE) -- Pono Capital Four, Inc. (Nasdaq: PONO) (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 12,000,000 units, at an offering price of $10.00 per unit, resulting in aggregate gross proceeds to the Company of $120,000,000. Each unit consists of one Class A ordinary share and one right (the “Share Right”) to receive one-fifth of one Class A ordinary share at the closing of the Company’s initial business combination. The units are listed on The Nasdaq Stock Market LLC (“Nasdaq”) and trade under the ticker symbol “PONOU”. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the Share Rights are expected to be traded on Nasdaq under the symbols “PONO” and “PONOR,” respectively.